During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
Widespread frost for most areas as temperatures dip below freezing.
Premier League clubs have agreed to pay all full-time staff the living wageof £9.15 an hour in London or £7.85 an hour outside the capital.
Tamworth represents what's going on at the national level, a remarkable boom in jobs but wages only just beginning to overtake inflation.